A Phase I, Pharmacokinetic and Tolerability Study of Intravenous Unfractionated Heparin After Subcutaneous Enoxaparin [enoxaparin sodium] 1mg/kg Bid Repeated Administration in Healthy Subjects.

Trial Profile

A Phase I, Pharmacokinetic and Tolerability Study of Intravenous Unfractionated Heparin After Subcutaneous Enoxaparin [enoxaparin sodium] 1mg/kg Bid Repeated Administration in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Mar 2011

At a glance

  • Drugs Enoxaparin sodium; Heparin
  • Indications Thrombosis
  • Focus Pharmacodynamics
  • Acronyms STACKENOX
  • Sponsors Sanofi
  • Most Recent Events

    • 14 Mar 2011 Last checked against ClinicalTrials.gov record.
    • 01 Aug 2009 Results published in the American Heart Journal.
    • 03 Sep 2008 Results of this study was published in the proceedings of the ESC Congress 2008: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top